(in millions $) | 31 Mar 2024 | 30 Sep 2023 | 31 Mar 2023 | 30 Sep 2022 |
---|---|---|---|---|
Current assets | ||||
Cash | $62863.6 | $171454.2 | $25743.8 | $18265.8 |
Short term investments | $42906.7 | $61790.6 | $42771.4 | $42653.8 |
Net receivables | $84789.5 | $58914.9 | $68664.2 | $50055.6 |
Inventory | $428361.3 | $441134.7 | $380691.9 | $445595.4 |
Total current assets | $656941.1 | $784142.6 | $560129.3 | $661578.6 |
Long term investments | $223399.2 | $219864.1 | $225011.4 | $222388.9 |
Property, plant & equipment | $933977.6 | $906295.2 | $901098.5 | $882425.7 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $2024177.5 | $2110034.5 | $1881087.7 | $1967705.5 |
Current liabilities | ||||
Accounts payable | $283058.1 | $283688.4 | $240242.6 | $251662.8 |
Deferred revenue | ||||
Short long term debt | $191217.6 | $152270 | $197415 | $285696.9 |
Total current liabilities | $808833.8 | $886785.2 | $748417.1 | $893416.1 |
Long term debt | $354772.9 | $411082.1 | $496345.3 | $524681.6 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $1267826.4 | $1400209.8 | $1345864.1 | $1500036.7 |
Shareholders' equity | ||||
Retained earnings | $636205.4 | $434723.2 | ||
Other shareholder equity | $734988.2 | $688530.2 | $513929.1 | $446374.3 |
Total shareholder equity | $756351.1 | $709824.7 | $535223.6 | $467668.8 |
(in millions $) | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $62863.6 | $25743.8 | $22366.9 | $74176.4 |
Short term investments | $42906.7 | $42771.4 | $50019.3 | $69511.6 |
Net receivables | $84789.5 | $68664.2 | $107383.6 | $93924.6 |
Inventory | $428361.3 | $380691.9 | $421787.4 | $267060.2 |
Total current assets | $656941.1 | $560129.3 | $619993.6 | $519824.9 |
Long term investments | $223399.2 | $225011.4 | $198806.4 | $199735.1 |
Property, plant & equipment | $933977.6 | $901098.5 | $864871.5 | $712342.6 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $2024177.5 | $1881087.7 | $1875286.3 | $1609920.3 |
Current liabilities | ||||
Accounts payable | $283058.1 | $240242.6 | $303477.2 | $162626.7 |
Deferred revenue | ||||
Short long term debt | $191217.6 | $197415 | $201345.4 | $111766.1 |
Total current liabilities | $808833.8 | $748417.1 | $830684.7 | $569303.8 |
Long term debt | $354772.9 | $496345.3 | $443996.6 | $433552.5 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $1267826.4 | $1345864.1 | $1356230.1 | $1074369.5 |
Shareholders' equity | ||||
Retained earnings | $636205.4 | $434723.2 | $497761.7 | $462421.2 |
Other shareholder equity | $734988.2 | $513929.1 | $16100.2 | -$1312.7 |
Total shareholder equity | $756351.1 | $535223.6 | $519056.2 | $535550.8 |
(in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $1130949.2 | $1165547.3 | $1154991.4 | $1030443.7 |
Cost of revenue | $1006099.9 | $995430.9 | $1019134.3 | $837511.3 |
Gross Profit | $124849.3 | $170116.4 | $135857.1 | $192932.4 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $7855.1 | $8549.8 | $10718.9 | $7626.4 |
Total operating expenses | $1091511.1 | $1091190.9 | $1111304.2 | $917091.3 |
Operating income | $39438.1 | $74356.4 | $43687.2 | $113352.4 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $10173.5 | $18796.8 | $11855.2 | $28121.9 |
Interest expense | -$8889.5 | -$9668 | -$7001.8 | -$9732.1 |
Net income | ||||
Net income | $28415.5 | $47895.7 | $31814.2 | $82435.5 |
Income (for common shares) | $28415.5 | $47895.7 | $31814.2 | $82435.5 |
(in millions $) | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $4503177.6 | $4731871.8 | $4325696.2 | $3042662.8 |
Cost of revenue | $3760961.5 | $4332122.9 | $3891798.1 | $2712337.1 |
Gross Profit | $742216.1 | $399748.9 | $433898.1 | $330325.7 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $35771.7 | $27750.1 | $34080 | $88401.5 |
Total operating expenses | $4105925.2 | $4686678.9 | $4177315.19 | $2819848.4 |
Operating income | $397252.4 | $45192.9 | $148381.01 | $222814.4 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $93356 | $6900.8 | $43552.3 | $51121.9 |
Interest expense | -$41488.9 | -$37453.8 | ||
Net income | ||||
Net income | $268588.4 | $21310.5 | $116815 | $161649.8 |
Income (for common shares) | $268588.4 | $21310.5 | $116815 | $161649.8 |
(in millions $) | 31 Mar 2022 | 30 Sep 2021 | 31 Mar 2021 | 30 Sep 2020 |
---|---|---|---|---|
Net income | $85290.5 | -$149243.4 | $224320.2 | $70874.3 |
Operating activities | ||||
Depreciation | $29349.8 | -$18348.4 | $43342.1 | $21377.5 |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $47970.4 | -$80152.2 | $235538.1 | $184190.5 |
Investing activities | ||||
Capital expenditures | -$43450.6 | $58003.5 | -$92059.2 | -$34028.4 |
Investments | ||||
Total cash flows from investing | -$37830.6 | -$17818 | -$25727.1 | -$43099.6 |
Financing activities | ||||
Dividends paid | -$140341.1 | $44756 | -$49242.7 | |
Sale and purchase of stock | $55195.3 | |||
Net borrowings | $41757.3 | $66023.8 | -$126541.4 | -$122337.3 |
Total cash flows from financing | -$107549.3 | $70641.5 | -$139809 | -$131454.8 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$97409.5 | -$27328.7 | $70002 | $9636.1 |
(in millions $) | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
---|---|---|---|---|
Net income | $268588.4 | $21310.5 | $160367.3 | $224320.2 |
Operating activities | ||||
Depreciation | $67712.6 | $63688.2 | $54343.5 | $43342.1 |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $359359 | $124656 | $203356.3 | $235538.1 |
Investing activities | ||||
Capital expenditures | -$95791.3 | -$85486.2 | -$77506.3 | -$92059.2 |
Investments | ||||
Total cash flows from investing | -$105205.8 | -$78064.1 | -$81375.7 | -$25727.1 |
Financing activities | ||||
Dividends paid | -$53288 | -$12815.7 | -$144827.8 | -$49242.7 |
Sale and purchase of stock | $3981 | $55195.3 | ||
Net borrowings | -$168446.5 | $1114.8 | -$18760.3 | -$126541.4 |
Total cash flows from financing | -$254273 | -$44020.1 | -$176716.8 | -$139809 |
Effect of exchange rate | -$1797.4 | |||
Change in cash and equivalents | -$119.8 | $2571.8 | -$54736.2 | $70002 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | $4.48T |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | $190.56B |
Revenue Q/Q | 0.10% |
Revenue Y/Y | -3.63% |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | 9.55% |
ROE | 30.87% |
Debt/Equity | 1.68 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.81 |
Quick ratio | 0.28 |